Evidence map›Paper›PMID 38612851›Full record

ArticleInternational journal of molecular sciences2024

Contrast Agents Based on Human Serum Albumin and Nitroxides for

Dmitry Mitin, Friedemann Bullinger, Sergey Dobrynin, Jörn Engelmann, Klaus Scheffler, Mikhail Kolokolov, Olesya Krumkacheva, Kai Buckenmaier, Igor Kirilyuk, Alexey Chubarov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Hybrid FeInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Albumin Is an Integrative Protein of Blood Plasma and Beyond.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Dmitry MitinInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.
Friedemann BullingerHigh-Field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany.
Sergey DobryninN.N. Vorozhtsov Institute of Organic Chemistry SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0003-3486-0335
Jörn EngelmannHigh-Field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany.
Klaus SchefflerHigh-Field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany.
Mikhail KolokolovInternational Tomography Center SB RAS, 630090 Novosibirsk, Russia.ORCID 0009-0001-8817-7358
Olesya KrumkachevaInternational Tomography Center SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0002-0777-5103
Kai BuckenmaierHigh-Field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, 72076 Tuebingen, Germany.
Igor KirilyukN.N. Vorozhtsov Institute of Organic Chemistry SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0001-6033-0368
Alexey ChubarovInstitute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.ORCID 0000-0002-5708-7595
Max Planck Institute for Biological Cybernetics · DEInstitute of Chemical Biology and Fundamental Medicine · RUInternational Tomography Center · RUNovosibirsk Institute of Organic Chemistry · RU

Funding

Deutsche Forschungsgemeinschaft BU 2694/9-1Russian Science Foundation 23-13-00178
6 · The paper itself

Abstract

In cancer diagnostics, magnetic resonance imaging (MRI) uses contrast agents to enhance the distinction between the target tissue and background. Several promising approaches have been developed to increase MRI sensitivity, one of which is Overhauser dynamic nuclear polarization (ODNP)-enhanced MRI (OMRI). In this study, a macromolecular construct based on human serum albumin and nitroxyl radicals (HSA-NIT) was developed using a new synthesis method that significantly increased the modification to 21 nitroxide residues per protein. This was confirmed by electron paramagnetic resonance (EPR) spectroscopy and matrix-assisted laser desorption/ionization time-of-flight (MALDI ToF) mass spectrometry. Gel electrophoresis and circular dichroism showed no significant changes in the structure of HSA-NITs, and no oligomers were formed during modification. The cytotoxicity of HSA-NITs was comparable to that of native albumin. HSA-NITs were evaluated as potential "metal-free" organic radical relaxation-based contrast agents for

Indexed as

NeoplasmsNitrogen OxidesSerum Albumin, HumanContrast MediaHumansMagnetic Resonance ImagingContrast MediaNitrogen OxidesnitroxylSerum Albumin, Humanhuman serum albuminmagnetic resonance imagingnitroxidesorganic radical contrast agentsOverhauser dynamic nuclear polarization (ODNP) enhanced magnetic resonance imaging (OMRI)spin probes

Identifiers

PMID38612851
PMCPMC11012161
OpenAlexW4393989045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.